The purpose of this study is to find out if estrogen, a female sex hormone, given as a patch
placed on skin of COVID19 positive or presumptive positive patients for 7 days can reduce the
severity of COVID19 symptoms compared to regular care.
This study has two study groups. One group will receive the study drug, a single-use Climara
25cm2 estrogen patch. The other group will receive standard of care.
Participants will be asked questions about their symptoms for up 6 times in up to 45 days.